MindMed to Participate at May Investor Conferences

Rhea-AI Summary

MindMed, a clinical stage biopharmaceutical company (NASDAQ: MNMD), will participate in investor conferences in May, including the 2024 RBCCM Global Healthcare Conference and HCW's 2nd Annual BioConnect Investor Conference. Members of the management team will engage in fireside chats and 1x1 investor meetings to discuss novel product candidates for brain health disorders.

NEW YORK--(BUSINESS WIRE)-- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management team will participate in the following investor conferences:

• 2024 RBCCM Global Healthcare Conference
  • Format: Fireside Chat
  • Date and Time: Wednesday, May 15, 2024 at 11:00 am EDT
  • Location: New York, NY
  • Webcast Link: 2024 RBCCM Global Healthcare Conference

• HCW's 2nd Annual BioConnect Investor Conference
  • Format: 1x1 investor meetings only
  • Date: May 20, 2024
  • Location: New York, NY

An audio webcast and replay of the fireside chat at the 2024 RBCCM Global Healthcare Conference will be accessible on MindMed’s Investor Relations website for up to 90 days following the event.

About MindMed

MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders. MindMed trades on NASDAQ under the symbol MNMD.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240509762996/en/

For Media: media@mindmed.co

For Investors: ir@mindmed.co

Source: MindMed

FAQ

What is the stock symbol for MindMed?

MindMed's stock symbol is MNMD.

When will MindMed participate in the 2024 RBCCM Global Healthcare Conference?

MindMed will participate in the 2024 RBCCM Global Healthcare Conference on Wednesday, May 15, 2024, at 11:00 am EDT.

Where will the HCW's 2nd Annual BioConnect Investor Conference take place?

The HCW's 2nd Annual BioConnect Investor Conference will take place in New York, NY.

How long will the audio webcast and replay of the fireside chat at the 2024 RBCCM Global Healthcare Conference be accessible?

The audio webcast and replay will be accessible on MindMed’s Investor Relations website for up to 90 days following the event.